Filing Details
- Accession Number:
- 0001062993-23-019821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-30 16:12:23
- Reporting Period:
- 2023-10-27
- Accepted Time:
- 2023-10-30 16:12:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1811623 | Paxmedica Inc. | PXMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1940128 | F John Coelho | C/O Paxmedica, Inc. 303 South Broadway, Suite 125 Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-10-27 | 570 | $0.19 | 79,090 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
- The sale price represents the weighted average sale price of the shares sold ranging from $0.187 to $0.1901 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Does not reflect a 1-for-17 reverse stock split effective October 30, 2023.
Billionaire Hedge Funds
